ObjectiveThis work aimed to investigate the transcriptome heterogeneity of dexamethasone-induced congenital cleft palate in homozygous New Zealand rabbits and determine the molecular mechanism underlying the occurrence of congenital cleft palate.MethodsDexamethasone (1.0 mg per day) was administered intramuscularly to 20 New Zealand pregnant rabbits from day 14 to day 17 of gestation, and the palatal phenotype of all offspring of each pregnant rabbit was observed. Eight embryos with a 4∶4 ratio of cleft palate to non-cleft palate were selected and divided into the cleft palate group (CP) and non-cleft palate group (NCP). Their palatal tissues were collected for RNA sequencing.ResultsA total of 225 differentially expressed genes (Q<0 .05) were found in the cp group compared with the ncp group, of which 120 genes were upregulated and 105 genes were downregulated. the go and kegg enrichment analyses of these differentially expressed genes were carried out. the results showed significant enrichment in go classification, which included heterotrimeric g protein complex, extracellular matrix, transcription factor complex, and basement membrane. meanwhile, gaba ergic synapse, morphine addiction, retrograde endocannabinoid signaling, glutamate synapse, serotonergic synapse, regulation of actin cytoskeleton, and the apelin signaling pathway were significantly enriched in the kegg pathway. compared with the ncp group, the gene expression levels of arhgef6 (P<0 .05) and abi2 (P<0 .001) decreased in the cp group, and apc increased (P<0 .001); these results were confirmed by real-time polymerase chain reaction.ConclusionAbnormal expression levels of the ARHGEF6, APC, and ABI2 genes involved in the regulation of the actin cytoskeleton in the palatal synapse may be associated with the dexamethasone-induced congenital cleft palate in New Zealand rabbits.
